Moshe Mittelman

6.6k total citations · 1 hit paper
186 papers, 3.3k citations indexed

About

Moshe Mittelman is a scholar working on Hematology, Genetics and Immunology. According to data from OpenAlex, Moshe Mittelman has authored 186 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 123 papers in Hematology, 53 papers in Genetics and 28 papers in Immunology. Recurrent topics in Moshe Mittelman's work include Acute Myeloid Leukemia Research (60 papers), Erythropoietin and Anemia Treatment (42 papers) and Multiple Myeloma Research and Treatments (20 papers). Moshe Mittelman is often cited by papers focused on Acute Myeloid Leukemia Research (60 papers), Erythropoietin and Anemia Treatment (42 papers) and Multiple Myeloma Research and Treatments (20 papers). Moshe Mittelman collaborates with scholars based in Israel, United States and Germany. Moshe Mittelman's co-authors include Drorit Neumann, Howard S. Oster, Max Gassmann, Aliza Zeidman, Guillermo Sanz, Alan N. Schechter, Amos Cohen, Miloslav Beran, John M. Bennett and Bruce D. Cheson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Oncology.

In The Last Decade

Moshe Mittelman

175 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Report of an international working group to standardize response criteria for myelodysplastic syndromes.

2000 524 citations Moshe Mittelman, Guillermo Sanz et al. PubMed profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Moshe Mittelman Israel	30	2.1k	1.0k	620	450	366	186	3.3k
Henrik Birgens Denmark	35	1.7k 0.8×	1.2k 1.1×	560 0.9×	353 0.8×	423 1.2×	96	3.6k
Robert T. Means United States	30	2.4k 1.2×	1.4k 1.4×	413 0.7×	263 0.6×	461 1.3×	71	3.7k
Irene Lorand‐Metze Brazil	27	1.2k 0.6×	622 0.6×	671 1.1×	438 1.0×	488 1.3×	205	2.5k
Nelson Hamerschlak Brazil	25	1.6k 0.8×	1.2k 1.2×	446 0.7×	588 1.3×	301 0.8×	269	3.2k
Guido Lucarelli Italy	35	2.7k 1.3×	2.7k 2.6×	410 0.7×	309 0.7×	274 0.7×	83	4.0k
Peter Jacobs South Africa	31	1.5k 0.7×	766 0.7×	418 0.7×	367 0.8×	921 2.5×	192	3.8k
Anand Padmanabhan United States	26	1.5k 0.7×	591 0.6×	282 0.5×	254 0.6×	885 2.4×	70	3.9k
Gordon L. Phillips United States	26	1.6k 0.7×	514 0.5×	476 0.8×	1.0k 2.2×	643 1.8×	87	3.8k
Geir E. Tjønnfjord Norway	37	2.9k 1.4×	1.6k 1.5×	722 1.2×	680 1.5×	1.4k 3.9×	217	5.7k
Jeanne M. Lusher United States	45	5.5k 2.6×	1.5k 1.5×	901 1.5×	298 0.7×	313 0.9×	173	6.9k

Countries citing papers authored by Moshe Mittelman

Since Specialization

Citations

This map shows the geographic impact of Moshe Mittelman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moshe Mittelman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moshe Mittelman more than expected).

Fields of papers citing papers by Moshe Mittelman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Moshe Mittelman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moshe Mittelman. The network helps show where Moshe Mittelman may publish in the future.

Co-authorship network of co-authors of Moshe Mittelman

This figure shows the co-authorship network connecting the top 25 collaborators of Moshe Mittelman. A scholar is included among the top collaborators of Moshe Mittelman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Moshe Mittelman. Moshe Mittelman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mittelman, Moshe. (2025). Introduction to the Review Series on Myelodysplasia. Haematologica. 110(2). 281–282.

Oster, Howard S., Arjan A. van de Loosdrecht, & Moshe Mittelman. (2024). Diagnosis of myelodysplastic syndromes: the classic and the novel. Haematologica. 110(2). 300–311. 2 indexed citations

Mittelman, Moshe, David H. Henry, John A. Glaspy, et al.. (2023). Efficacy and Safety of Roxadustat for Treatment of Anemia in Patients with Lower-Risk Myelodysplastic Syndrome (LR-MDS) with Low Red Blood Cell (RBC) Transfusion Burden: Results of Phase III Matterhorn Study. Blood. 142(Supplement 1). 195–195. 3 indexed citations

Oster, Howard S., et al.. (2023). Routine inflammatory markers are elevated in myelodysplastic syndromes at presentation. Mediterranean Journal of Hematology and Infectious Diseases. 15(1). e2023044–e2023044. 1 indexed citations

Mittelman, Moshe, Noam Barda, Noa Dagan, et al.. (2021). Effectiveness of the BNT162b2mRNA COVID-19 vaccine in patients with hematological neoplasms in a nationwide mass vaccination setting. Blood. 139(10). 1439–1451. 43 indexed citations

Avivi, Irit, M. Morales, Anat Aharon, et al.. (2021). Humoral response rate and predictors of response to BNT162b2 mRNA COVID19 vaccine in patients with multiple myeloma. British Journal of Haematology. 195(2). 186–193. 50 indexed citations

Conrads‐Frank, Annette, Ursula Rochau, Karin A. Koinig, et al.. (2021). Core set of patient-reported outcomes for myelodysplastic syndromes: an EUMDS Delphi study involving patients and hematologists. Blood Advances. 6(1). 1–12. 4 indexed citations

Trestman, Svetlana, Yaël C. Cohen, Yoel Angel, et al.. (2020). Components of metabolic syndrome in patients with multiple myeloma and smoldering multiple myeloma. BMC Cancer. 20(1). 489–489. 8 indexed citations

Joffe, Erel, Uri Greenbaum, Kalman Filanovsky, et al.. (2020). Kinetics of pre‐myelodysplastic syndromes blood values correlate with disease risk and survival. Hematological Oncology. 38(5). 782–791. 1 indexed citations

10.

Ben‐Califa, Nathalie, Sahar Hiram‐Bab, Tamar Liron, et al.. (2020). Erythropoietin receptor in B cells plays a role in bone remodeling in mice. Theranostics. 10(19). 8744–8756. 19 indexed citations

11.

Greenbaum, Uri, Erel Joffe, Kalman Filanovsky, et al.. (2018). Can bone marrow cellularity help in predicting prognosis in myelodysplastic syndromes?. European Journal Of Haematology. 101(4). 502–507. 8 indexed citations

12.

Johnston, W. Thomas, Alexandra Smith, Louise de Swart, et al.. (2016). Erythropoiesis‐stimulating agents significantly delay the onset of a regular transfusion need in nontransfused patients with lower‐risk myelodysplastic syndrome. Journal of Internal Medicine. 281(3). 284–299. 22 indexed citations

13.

Souroujon, Miriam C., et al.. (2014). Resistance of LPS-activated bone marrow derived macrophages to apoptosis mediated by dexamethasone. Scientific Reports. 4(1). 4323–4323. 23 indexed citations

14.

Katz, Odelia, Matthew Stuible, Michel L. Tremblay, et al.. (2010). Erythropoietin treatment leads to reduced blood glucose levels and body mass: insights from murine models. Journal of Endocrinology. 205(1). 87–95. 68 indexed citations

15.

Ziv, Amitai, Orit Rubin, Naomi Gafni, et al.. (2008). MOR: a simulation‐based assessment centre for evaluating the personal and interpersonal qualities of medical school candidates. Medical Education. 42(10). 991–998. 52 indexed citations

16.

Bs, Lewis, Avraham Shotan, Shmuel Gottlieb, et al.. (2007). Late mortality and determinants in patients with heart failure and preserved systolic left ventricular function: the Israel Nationwide Heart Failure Survey.. PubMed. 9(4). 234–8. 17 indexed citations

17.

Boogaerts, Marc, Moshe Mittelman, & Peter Vaupel. (2005). Beyond Anaemia Management: Evolving Role of Erythropoietin Therapy in Neurological Disorders, Multiple Myeloma and Tumour Hypoxia Models. Oncology. 69(Suppl. 2). 22–30. 14 indexed citations

18.

Nyska, Meir, Shay Shabat, Philip H. Long, et al.. (2005). Disseminated Thrombosis-Induced Growth Plate Necrosis in Rat. Journal of Pediatric Orthopaedics. 25(3). 346–350. 6 indexed citations

19.

Eting, Eva, et al.. (1996). Ocular Manifestation of Hairy Cell Leukemia With Dramatic Response to 2-Chloro-deoxy-adenosine. American Journal of Ophthalmology. 121(1). 97–99. 7 indexed citations

20.

Mittelman, Moshe, et al.. (1992). Myelokathexis and Monocytosis in a Patient with Gastric Cancer. Acta Haematologica. 87(4). 210–212. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact